Anti-PLS4/ PLSCR4/ TRA1 monoclonal antibody

Anti-PLS4/ PLSCR4/ TRA1 antibody for FACS & in-vivo assay

Target products collectionGo to PLSCR4/PLSCR4 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP1384-Ab-1/ GM-Tg-hg-MP1384-Ab-2Anti-Human PLSCR4 monoclonal antibodyHuman
GM-Tg-rg-MP1384-Ab-1/ GM-Tg-rg-MP1384-Ab-2Anti-Rat PLSCR4 monoclonal antibodyRat
GM-Tg-mg-MP1384-Ab-1/ GM-Tg-mg-MP1384-Ab-2Anti-Mouse PLSCR4 monoclonal antibodyMouse
GM-Tg-cynog-MP1384-Ab-1/ GM-Tg-cynog-MP1384-Ab-2Anti-Cynomolgus/ Rhesus macaque PLSCR4 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP1384-Ab-1/ GM-Tg-felg-MP1384-Ab-2Anti-Feline PLSCR4 monoclonal antibodyFeline
GM-Tg-cang-MP1384-Ab-1/ GM-Tg-cang-MP1384-Ab-2Anti-Canine PLSCR4 monoclonal antibodyCanine
GM-Tg-bovg-MP1384-Ab-1/ GM-Tg-bovg-MP1384-Ab-2Anti-Bovine PLSCR4 monoclonal antibodyBovine
GM-Tg-equg-MP1384-Ab-1/ GM-Tg-equg-MP1384-Ab-2Anti-Equine PLSCR4 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP1384-Ab-1/ GM-Tg-hg-MP1384-Ab-2; GM-Tg-rg-MP1384-Ab-1/ GM-Tg-rg-MP1384-Ab-2;
GM-Tg-mg-MP1384-Ab-1/ GM-Tg-mg-MP1384-Ab-2; GM-Tg-cynog-MP1384-Ab-1/ GM-Tg-cynog-MP1384-Ab-2;
GM-Tg-felg-MP1384-Ab-1/ GM-Tg-felg-MP1384-Ab-2; GM-Tg-cang-MP1384-Ab-1/ GM-Tg-cang-MP1384-Ab-2;
GM-Tg-bovg-MP1384-Ab-1/ GM-Tg-bovg-MP1384-Ab-2; GM-Tg-equg-MP1384-Ab-1/ GM-Tg-equg-MP1384-Ab-2
Products NameAnti-PLSCR4 monoclonal antibody
Formatmab
Target NamePLSCR4
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-PLSCR4 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species PLS4/ PLSCR4/ TRA1 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorvGMLP003169human PLSCR4 Lentivirus particle
    ORF Viral VectorpGMLP003169human PLSCR4 Lentivirus plasmid
    ORF Viral VectorpGMAAV000103mouse Plscr4 AAV plasmid
    ORF Viral VectorvGMAAV000103mouse Plscr4 AAV particle


    Target information

    Target IDGM-MP1384
    Target NamePLSCR4
    Gene ID57088,235527,300900,713430,611495,101085489,539290,100060925
    Gene Symbol and SynonymsPls4,PLSCR4,TRA1
    Uniprot AccessionQ9NRQ2
    Uniprot Entry NamePLS4_HUMAN
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseN/A
    Gene EnsemblENSG00000114698
    Target ClassificationN/A

    The target: PLSCR4, gene name: PLSCR4, also named as TRA1. Enables CD4 receptor binding activity and enzyme binding activity. Predicted to be involved in plasma membrane phospholipid scrambling. Predicted to act upstream of or within cellular response to lipopolysaccharide. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2022].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.